Home > Press > HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care
 |
Abstract:
HORIBA Medical, a subsidiary of Japan-based HORIBA Group, the global leader for measurement and analysis systems, has been designing, manufacturing and marketing high performance analyzers for laboratories and hospitals for over 30 years. This expertise that has made the company one of the world leaders in Hematology and a key player in the Hemostasis and Clinical Chemistry activity.
HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care
Montpellier and Grenoble, France | Posted on July 21st, 2020
Today, patient care and treatment practices are evolving quickly. HORIBA Medical is designing solutions to anticipate patient-centered needs by developing new POCT (Point of Care Testing) systems.
In parallel, for the past six years HORIBA Medical has been working with one of the most innovative organizations in the field of new technologies, CEA-Leti, the technology research laboratory of CEA Tech, federating their respective skills in a Joint Laboratory called HEMACOUNT.
“We focused on two disruptive technologies: a microfluidic cartridge and a new, lens-free imaging device (LensFree), which will enable development of more compact, easier-to-use POCT-type devices,” says Damien Isebe, who heads up this highly innovative project at HORIBA Medical. “Twelve families of patents have been filed since the start of the project, and the latest one has been the subject of several scientific papers”.
“Flow cytometry is the main analytical technology in hematology, but it requires large and complex hardware systems. Conversely, lens-free imaging combined with a sample prepared as a microfluidic cartridge paves the way to a simple and compact disruptive architecture. This imaging technique provides a wide field of view (≈30mm²) resulting in a counting statistic (a few thousand cells) in one single acquisition consistent with required hematological performance,” explains Sophie Morales, laboratory head at CEA-Leti.
The latest publications and presentations to date: for LensFree, one publication in the Journal of Biomedical Optics and two oral presentations at ECBO (European Conferences on Biomedical Optics), held in Munich in late June 2019; and for the work on microfluidics, presentation of a scientific poster at µTAS (International Conference on Miniaturized Systems for Chemistry and Life Sciences) in Basel, Switzerland, in October 2019.
Given the success of the partnership and the work that remains to be done, HORIBA Medical is pleased to announce the continuation of this collaboration, which will allow it to draw value from this work in the form of innovative applications, to bring developments to maturity and to design products that will serve care-givers and patients.
Patents: DD17052- FR1663028: “Procedure for counting particles in a sample by lens-free imaging”
####
About Leti
Leti, a technology research institute at CEA, is a global leader in miniaturization technologies enabling smart, energy-efficient and secure solutions for industry. Founded in 1967, CEA-Leti pioneers micro-& nanotechnologies, tailoring differentiating applicative solutions for global companies, SMEs and startups. CEA-Leti tackles critical challenges in healthcare, energy and digital migration. From sensors to data processing and computing solutions, CEA-Leti’s multidisciplinary teams deliver solid expertise, leveraging world-class pre-industrialization facilities. With a staff of more than 1,900, a portfolio of 3,100 patents, 10,000 sq. meters of cleanroom space and a clear IP policy, the institute is based in Grenoble, France, and has offices in Silicon Valley and Tokyo. CEA-Leti has launched 65 startups and is a member of the Carnot Institutes network. Follow us on www.leti-cea.com and @CEA_Leti.
About HORIBA Medical
HORIBA Medical offers an extensive and comprehensive line of hematology, coagulation and clinical chemistry solutions (including reagents) for in vitro diagnostics. The HORIBA Medical brand has earned the trust of a wide customer base through the quality and reliability of its products. Today, over 30,000 laboratories around the world use HORIBA Medical solution (more information at: www.horiba.com).
For more information, please click here
Contacts:
Press Contact HORIBA Medical
Carole Barascud
Public and Media Relations
Tel. +33.4.67.14.15.59
Press Contact CEA-Leti
Agency
Tel. +33 6 74 93 23 47
Copyright © Leti
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Membrane technology could cut emissions and energy use in oil refining July 17th, 2020
New cobalt-free lithium-ion battery reduces costs without sacrificing performance July 17th, 2020
Scientists open new window into the nanoworld July 17th, 2020
Imaging
Scientists open new window into the nanoworld July 17th, 2020
Porous graphene ribbons doped with nitrogen for electronics and quantum computing July 10th, 2020
Developing new techniques to improve atomic force microscopy June 26th, 2020
Chemistry
Rock ‘n’ control: Göttingen physicists use oscillations of atoms to control a phase transition July 8th, 2020
Fluorocarbon bonds are no match for light-powered nanocatalyst: Rice U. lab unveils catalyst that can break problematic C-F bonds June 22nd, 2020
First measurement of electron energy distributions, could enable sustainable energy technologies June 5th, 2020
Possible Futures
Streamlining quantum information transmission July 17th, 2020
‘Blinking” crystals may convert CO2 into fuels: Unusual nanoparticles could benefit the quest to build a quantum computer July 17th, 2020
New cobalt-free lithium-ion battery reduces costs without sacrificing performance July 17th, 2020
Nanomedicine
Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020
Wearable patch may provide new treatment option for skin cancer June 18th, 2020
Tiny pump builds polyrotaxanes with precision: Artificial molecular pump gives precise control for materials design June 12th, 2020
Discoveries
‘Blinking” crystals may convert CO2 into fuels: Unusual nanoparticles could benefit the quest to build a quantum computer July 17th, 2020
Membrane technology could cut emissions and energy use in oil refining July 17th, 2020
New cobalt-free lithium-ion battery reduces costs without sacrificing performance July 17th, 2020
Scientists open new window into the nanoworld July 17th, 2020
Announcements
Membrane technology could cut emissions and energy use in oil refining July 17th, 2020
New cobalt-free lithium-ion battery reduces costs without sacrificing performance July 17th, 2020
Scientists open new window into the nanoworld July 17th, 2020
Patents/IP/Tech Transfer/Licensing
New green technology from UMass Amherst generates electricity ‘out of thin air’ Renewable device could help mitigate climate change, power medical devices February 17th, 2020
The Wave of the Future: Researchers achieve first successful generation and detection of pure spin currents in antiferromagnetic materials January 29th, 2020
Supercharging tomorrow: Monash develops world’s most efficient lithium-sulfur battery January 3rd, 2020
Nanobiotechnology
Charcoal a weapon to fight superoxide-induced disease, injury: Nanomaterials soak up radicals, could aid treatment of COVID-19 July 2nd, 2020
Wearable patch may provide new treatment option for skin cancer June 18th, 2020
Tiny pump builds polyrotaxanes with precision: Artificial molecular pump gives precise control for materials design June 12th, 2020
Research partnerships
‘Blinking” crystals may convert CO2 into fuels: Unusual nanoparticles could benefit the quest to build a quantum computer July 17th, 2020
Scientists open new window into the nanoworld July 17th, 2020
